Highlights and Quick Summary
- Financing cash flow for the quarter ending June 30, 2023 was $-34 Thousand (a -100.34% decrease compared to previous quarter)
- Year-over-year quarterly Financing cash flow decreased by -236.0%
- Annual Financing cash flow for 2022 was $83 Thousand (a -99.84% decrease from previous year)
- Annual Financing cash flow for 2021 was $50.5 Million (a 222.68% increase from previous year)
- Annual Financing cash flow for 2020 was $15.7 Million (a -19.7% decrease from previous year)
- Twelve month Financing cash flow ending June 30, 2023 was $10 Million (a -0.6% decrease compared to previous quarter)
- Twelve month trailing Financing cash flow increased by 4669.05% year-over-year
Trailing Financing cash flow for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $10 Million | $10.1 Million | $83 Thousand | $210 Thousand |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Financing cash flow of DURECT Corporation
Most recent Financing cash flowof DRRX including historical data for past 10 years.Interactive Chart of Financing cash flow of DURECT Corporation
DURECT Corporation Financing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-0.03 | $10.0 | – | – | – |
| 2022 | $0.02 | $0.03 | $0.03 | $0.01 | $0.08 |
| 2021 | $0.15 | $-0.12 | $-0.55 | $51.05 | $50.53 |
| 2020 | $0.45 | $7.1 | $7.35 | $0.76 | $15.66 |
| 2019 | $3.86 | $0.24 | $15.34 | $0.06 | $19.5 |
| 2018 | $-0.86 | $-0.0 | $4.24 | $14.1 | $17.48 |
| 2017 | $2.53 | $5.06 | $4.27 | $0.76 | $12.62 |
| 2016 | $3.58 | $0.94 | $17.24 | $1.32 | $23.08 |
| 2015 | $2.83 | $-0.11 | $12.24 | $0.24 | $15.2 |
| 2014 | $0.08 | $4.73 | $19.89 | $0.09 | $24.79 |
| 2013 | – | $10.84 | $0.06 | $0.08 | $10.98 |
| 2012 | $11.73 | – | – | – | $11.84 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic